In Vivo Efficacy of Anti-CD20-Interferon-Gamma Fusion Protein Against Syngeneic B Cell Lymphoma Is Mediated By Natural Killer Cells

被引：0
|
作者：
Vasuthasawat, Alex [1 ]
Yamada, Reiko E. [2 ]
Trinh, Kham R. [1 ]
Rokni, Neiki [2 ]
Morrison, Sherie L. [1 ]
Timmerman, John M. [2 ]
机构：
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-131890
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1575
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Significantly targeting rituximab resistant B-cell lymphoma (BL) by anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer (NK) cells.
    Chu, Yaya
    Ayello, Janet
    Yahr, Ashlin
    Katz, Jared
    Lo, Lowrence
    Flowers, Allyson
    Cairo, Mitchell S.
    CANCER RESEARCH, 2013, 73
  • [32] CD55 and CD59 Can Limit the Anti-Tumor Efficacy of Daratumumab in Natural Killer/T-Cell Lymphoma
    Mustafa, Nurulhuda
    Nee, Adina Huey Fang
    Chooi, Jing Yuan
    Toh, Sabrina Hui Min
    Hee, Yan Ting
    Selvarajan, Viknesvaran
    Zhou, Longen
    Yang, Jennifer
    Chng, Wee Joo
    BLOOD, 2018, 132
  • [33] Enhancement of anti-tumor activity of natural killer cells by BALL-1, a B cell lymphoma line
    Hirashima, M
    Yoshida, N
    Seki, M
    Okada, H
    Takamura, S
    Mihara, Y
    JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (04): : 427 - 435
  • [34] Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma
    Forero, A
    Weiden, PL
    Vose, JM
    Knox, SJ
    LoBuglio, AF
    Hankins, J
    Goris, ML
    Picozzi, VJ
    Axworthy, DB
    Breitz, HB
    Sims, RB
    Ghalie, RG
    Shen, S
    Meredith, RF
    BLOOD, 2004, 104 (01) : 227 - 236
  • [35] Anti-CD20 chimeric antigen receptor modified expanded natural killer cells have significant cytotoxicity against poor risk CD20+ Burkitt lymphoma in vitro and in xenografted NSG mice
    Chu, Yaya
    Yahr, Ashlin
    Lee, Fangyu
    Hochberg, Jessica
    Ayello, Janet
    van de Ven, Carmella
    Flower, Allyson
    Barth, Matthew
    Czuczman, Myron
    Cairo, Mitchell S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 44 - 45
  • [36] High infiltration of CD20+B lymphocytes in extranodal natural killer/T-cell lymphoma is associated with better prognosis
    Chen, Min-Min
    Zeng, Guo-Peng
    Li, Jing
    Fu, Jun-Hong
    Long, Ya-Yi
    Pan, Jie-Ying
    Wei, Lin-Zhi
    Guan, Jie-Ying
    Lin, Ying-Xi
    You, Hua
    Si, Cheng
    Li, Wen-Xing
    Liang, Yi-Jun
    Liu, Da-Hai
    Liu, Fang
    Liu, Fang
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (05) : E116 - E120
  • [37] Characterization of a humanized anti-CD20 antibody with potent antitumor activity against B-cell lymphoma
    Wu, Lan
    Wang, Chong
    Zhang, Dapeng
    Zhang, Xunming
    Qian, Weizhu
    Zhao, Lei
    Wang, Hao
    Li, Bohua
    Guo, Yajun
    CANCER LETTERS, 2010, 292 (02) : 208 - 214
  • [38] Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine model
    Schiffer, S.
    Hansen, H. P.
    Hehmann-Titt, G.
    Huhn, M.
    Fischer, R.
    Barth, S.
    Thepen, T.
    BLOOD CANCER JOURNAL, 2013, 3 : e106 - e106
  • [39] Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine model
    S Schiffer
    H P Hansen
    G Hehmann-Titt
    M Huhn
    R Fischer
    S Barth
    T Thepen
    Blood Cancer Journal, 2013, 3 : e106 - e106
  • [40] Antibody-Interferon-Alpha Fusion Protein Therapy for the Treatment of B-Cell Non-Hodgkin Lymphoma: Enhanced ADCC, Inhibition of Proliferation, and In Vivo Eradication of CD20+Human Lymphomas
    Timmerman, John M.
    Steward, Kristopher K.
    Yamada, Reiko E.
    Young, Patricia A.
    Minning, Dena M.
    Sachdev, Raj K.
    Gresser, Michael J.
    Khare, Sanjay D.
    Morrison, Sherie L.
    BLOOD, 2015, 126 (23)
12345